Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial.

Østergaard, Mikkel; Wu, Joseph; Fallon, Lara; Sherlock, Sarah P; Wang, Cunshan; Fleishaker, Dona; Kanik, Keith S; Maksymowych, Walter P

Østergaard, Mikkel; Wu, Joseph; Fallon, Lara; Sherlock, Sarah P; Wang, Cunshan; Fleishaker, Dona; Kanik, Keith S; Maksymowych, Walter P.

Afiliación

Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Valdemar Hansens Vej 17, 2600, Glostrup, Copenhagen, Denmark. mo@dadlnet.dk.
Wu J; Pfizer Inc, Groton, CT, USA.
Fallon L; Pfizer Canada ULC, Kirkland, QC, Canada.
Sherlock SP; Pfizer Inc, Cambridge, MA, USA.
Wang C; Pfizer Inc, Groton, CT, USA.
Fleishaker D; Pfizer Inc, Groton, CT, USA.
Kanik KS; Pfizer Inc, Groton, CT, USA.
Maksymowych WP; Department of Medicine, University of Alberta, and CARE Arthritis, Edmonton, AB, Canada.

Rheumatol Ther ; 10(4): 1001-1020, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37331992

Palabras clave

Ankylosing spondylitis; Clinical trial; Magnetic resonance imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Rheumatol Ther Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google